HYFM Earnings

HYFM reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 29.35M against an estimate of 35.73M, resulting in a -17.85% surprise. The EPS was -3.51, surpassing the expected -3.09 by -13.59%. The stock experienced a -16.08% price change on the earnings day and a -21.91% change over the next five days, reflecting market reactions to the results.

Following HYFM's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -16.08% on the day of the release. Over the subsequent five days, it saw a -21.91% change. Historically, HYFM's stock price tends to shift by an average of 14.97% in the 10 days leading up to earnings and -4.97% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate HYFM's annual revenue to reach 34.80M, while the EPS is projected at -2.60. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HYFM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HYFM's stock price typically moves by 14.97% in the 10 days before its earnings and -4.97% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -2.60 and revenue of 34.80M.

The earnings call revealed significant financial challenges, including a sharp decline in net sales and gross profit, high debt levels, and restructuring costs. The withdrawal of full-year guidance adds uncertainty, and management's vague responses to tariff and cannabis questions further raise concerns. Despite cost-saving efforts and optimism for future demand, the immediate outlook remains negative, especially with the absence of a clear recovery strategy.